Bosutinib mitigates inflammation in experimental sepsis
European Journal of Clinical Investigation · 2025
DOI: 10.1111/eci.70055 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2025. Verfasst von C M C Cunha und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Aniline Compounds, Sepsis, Nitriles, Quinolines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade Federal Fluminense (PROPPI/UFF), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Universidade Federal do Estado do Rio de Janeiro (UNIRIO).
Themen: Sepsis
Abstract (Originalsprache)
Background
Sepsis, a leading cause of death globally, lacks targeted and effective treatment. Its pathophysiology involves unbalanced inflammation, marked by a high release of inflammatory mediators, leukocyte recruitment, vascular changes and dysfunction of the nervous and respiratory systems. Src family tyrosine kinases (SFK) play a critical role in immune responses, and their inhibition can modulate excessive inflammation. This study investigates the potential of bosutinib, an SFK inhibitor, as a treatment for sepsis.
Methods
Clinical signs, survival rates, systemic and neuronal inflammatory responses, cell recruitment, lung function and cerebral microcirculation were analysed in mice treated with bosutinib (3 mg/kg) or DMSO/saline followed by cecal ligation and puncture (CLP)‐induced sepsis.
Results
Bosutinib treatment reduced the severity of sepsis, improved survival rates and reduced the levels of pro‐inflammatory cytokines and chemokines in peritoneal lavage, plasma and brain tissue. It also reduced cellular infiltration and bacterial growth at the infection site and protected lung function by reducing diffuse alveolar damage. Using intravital microscopy and laser speckle techniques, bosutinib improved capillary density and blood perfusion and reduced leukocyte recruitment and adhesion in the cerebral microcirculation of septic animals.
Conclusions
Bosutinib pretreatment attenuated dysregulated inflammatory responses and neurovascular changes in experimental sepsis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil.
- Laboratório de Imunofarmacologia, Instituto Biomédico, Universidade Federal Do Estado Do Rio de Janeiro, Rio de Janeiro, Brazil.
- Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
- Walter Brendel Centre, Department of Cardiovascular Physiology and Pathophysiology, Klinikum der Universität, Ludwig Maximilians University München, Munich, Germany.
ORCID-Profile: M Sperandio, P T Bozza, C F Gonçalves-de-Albuquerque
Förderung
- Universidade Federal Fluminense (PROPPI/UFF)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
- Universidade Federal do Estado do Rio de Janeiro (UNIRIO)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)
- Programa de Biotecnologia da Universidade Federal Fluminense (UFF)
- Programa de Pós Graduação em Biologia Molecular Celular (UNIRIO)
- Deutsche Forschungsgemeinschaft (DFG) TRR332
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Zitieren
APA
Cunha, C. M. C., Abreu, V. H. P., Estato, V., Soares, G. M. V., Moraes, B. P. T., Oliveira, G. P., Silva, J. D., Silva, P. L., Immler, R., Rocco, P. R., Sperandio, M., Silva, A. R., Bozza, P. T., Castro-Faria-Neto, H. C., & Gonçalves-de-Albuquerque, C. F. (2025). Bosutinib mitigates inflammation in experimental sepsis. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.70055
Vancouver
Cunha CMC, Abreu VHP, Estato V, Soares GMV, Moraes BPT, Oliveira GP, et al. Bosutinib mitigates inflammation in experimental sepsis. European Journal of Clinical Investigation. 2025. doi:10.1111/eci.70055
BibTeX
@article{Cunha2025,
author = {Cunha, C M C and Abreu, V H P and Estato, V and Soares, G M V and Moraes, B P T and Oliveira, G P and Silva, J D and Silva, P L and Immler, R and Rocco, P R and Sperandio, M and Silva, A R and Bozza, P T and Castro-Faria-Neto, H C and Gonçalves-de-Albuquerque, C F},
title = {Bosutinib mitigates inflammation in experimental sepsis},
journal = {European Journal of Clinical Investigation},
year = {2025},
doi = {10.1111/eci.70055}
}
EUVIMED